SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) January 22, 1999
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
Biocontrol Technologies, Inc. (OTCBB:BICO) announced
today that the Diasensorr1000 noninvasive glucose sensor made its
debut on national television this morning on CBS-TV's "This
Morning" show, featured as one of several products that represent
the growing area of "painless medicine." The Diasensor 1000 is
the world's first commercially available noninvasive testing
device for monitoring the blood sugar levels of diabetics. The
Company is also currently developing an internet marketing plan
that will wrap the Diasensor 1000 into a diabetic home-care
telehealth program utilizing the Diasensor for internet transfer
of extensive patient data.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired -
Not Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: January 22, 1999
BICO
BIOCONTROL TECHNOLOGY, INC
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.429.0673 phone
1.412.279.9690 fax 1.412.279.5041 fax
BIOCONTROL DIASENSOR 1000 SEEN ON CBS-TV'S "THIS MORNING"
Pittsburgh, PA - January 22, 1999 - Biocontrol Technology,
Inc. (OTCBB:BICO) announced today that the Diasensorr1000
noninvasive glucose sensor made its debut on national television
this morning on CBS-TV's "This Morning" show, featured as one of
several products that represent the growing area of "painless
medicine." The Diasensor 1000 is the world's first commercially
available noninvasive testing device for monitoring the blood
sugar levels of diabetics. Near infrared light penetrates the
patient's skin, picks up a particular pattern in the blood, and
reflects this information to the Diasensor's computer. The
patient's glucose reading is then displayed. The device is
completely noninvasive, uses no extra supplies, and can store a
significant amount of patient data. Designed for in-home use by
individual diabetic patients, the Diasensor 1000 has already
received the CE Mark and is therefore available in Europe.
The Company is also currently developing an internet
marketing plan that will wrap the Diasensor 1000 into a diabetic
home-care telehealth program utilizing the Diasensor for internet
transfer of extensive patient data.
Biocontrol Technology has its corporate offices in
Pittsburgh, PA and is involved in the development and manufacture
of biomedical devices and environmental products. The Diasensor
is marketed by subsidiary Diasensor.com, Inc. also located in
Pittsburgh, PA. Diasensor.com owns the patent, marketing and
distribution rights to the sensor while Biocontrol has the
exclusive rights to the research and development and
manufacturing of the sensor.
WEBSITE: www.bico.com
INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204
